March 1, 2017 / 2:25 PM / 7 months ago

BRIEF-Forward Pharma appoints Claus Bo Svendsen as CEO

March 1 (Reuters) - Forward Pharma A/S

* Forward Pharma appoints Claus Bo Svendsen as chief executive officer and plans to reorganize to reduce burn rate following the settlement and license agreement with biogen

* Forward Pharma A/S - Svendsen succeeds Peder M. Andersen

* Forward Pharma A/S - plans to wind up its remaining research and development efforts

* Forward Pharma A/S - Andersen will retain his role as chief operating officer and serve until September 1, 2017

* Forward Pharma A/S - plans to pursue an organizational realignment to reduce personnel and operating expenses by mid-year 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below